Article
The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers.
BMC neuroscience - 30 Sept 2009
Martínez Manuel Fernández, Martín Xabier Elcoroaristizabal, Alcelay Luís Galdos, Flores Jessica Castro, Valiente Juan María Uterga, Juanbeltz Begoña Indakoetxea, Beldarraín María Angeles Gómez, López Josefa Moraza, Gonzalez-Fernández María Carmen, Salazar Ana Molano, Gandarias Rocio Bereincua, Borda Sandra Inglés, Marqués Nuria Ortiz, Amillano Miryam Barandiarán, Zabaleta María Carrasco, de Pancorbo Marian M
Abstract excerpt
BACKGROUND: The aim of this study is to examine the influence of the catechol-O-methyltranferase (COMT) gene (polymorphism Val158 Met) as a risk factor for Alzheimer's disease (AD) and mild cognitive impairment of amnesic type (MCI), and its synergistic effect with the apolipoprotein E gene (APOE...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
